Christopher Sarchi
Corporate Officer/Principal presso REPLIMUNE GROUP, INC.
Patrimonio netto: 830 268 $ in data 30/06/2024
Profilo
Christopher Sarchi is currently the Chief Commercial Officer at Replimune Group, Inc. He previously worked as the Director-Oncology Regional Sales at Genentech, Inc. from 2010 to 2013.
He also held the position of Head-Commercial Oncology US Region at Sanofi.
Mr. Sarchi completed his undergraduate degree at the University of Maine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.15% | 16/05/2024 | 92 252 ( 0.15% ) | 830 268 $ | 30/06/2024 |
Posizioni attive di Christopher Sarchi
| Società | Posizione | Inizio |
|---|---|---|
| REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 03/01/2023 |
Precedenti posizioni note di Christopher Sarchi
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2013 |
| SANOFI | Corporate Officer/Principal | - |
Formazione di Christopher Sarchi
| University of Maine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Sarchi
